Viet Nam Completes ASF Vaccine Delivery to Philippines
The final shipment of a 300,000-dose order arrived following the country's recent commercial approval.
Updated on Oct. 28, 2026 in Veterinary Medicine
Live Poll
Do you support the rapid commercial rollout of new vaccines to control livestock disease outbreaks?
AVAC Viet Nam Joint Stock Company has shipped 100,000 doses of an African Swine Fever (ASF) vaccine to the Philippines. This delivery completes a total order of 300,000 doses intended to support ongoing vaccination efforts.
Why it matters
The shipment provides additional resources for controlling the spread of ASF, a significant threat to global pork production. Ongoing utilization remains focused on preventing the disease in non-infected animals.
The Philippines granted commercial approval for the vaccine on September 2, 2026. As of May 2026, the country had already administered 500,000 doses to its livestock population.
The players
AVAC Viet Nam Joint Stock Company
This is a Viet Nam-based biotechnology firm responsible for the research, development, and manufacturing of the African Swine Fever vaccine.
Philippine Department of Agriculture
This government agency oversees the agricultural sector in the Philippines and is responsible for establishing regulatory guidelines for livestock health.
The details
The vaccine is authorized strictly for market pigs and does not treat animals already infected with ASF. Effective administration requires strict cold-chain management and compliance with specific veterinary instructions.
Timeline
May 2026: 500,000 vaccine doses were administered in the Philippines.
September 2, 2026: The Philippines granted commercial approval for the vaccine.
October 28, 2026: AVAC shipped the final 100,000 vaccine doses.
Culture Shift
The rollout follows the ongoing clinical evaluation of ASF vaccines for sows, which remains a critical research barrier. While current market pigs receive the treatment, industry adoption hinges on future studies expanding the vaccine's scope.
Veterinarians and producers must ensure they follow specific manufacturer instructions regarding herd-health assessments and cold-chain storage. Proper compliance is essential for the vaccine to be effective in market pigs.
The takeaway
Producers should prioritize strict adherence to cold-chain and dosing protocols to ensure maximum vaccine efficacy. Future expansion of this treatment to sows is pending further scientific validation and regulatory review.
Further reading
Learn more about the latest developments in animal health at Veterinary Medicine.
Live Poll
Do you support the rapid commercial rollout of new vaccines to control livestock disease outbreaks?
